Viyash Scientific Announces Postal Ballot for Director Appointments & Performance Incentive
Viyash Scientific is seeking shareholder approval via postal ballot for appointing Mr. Amit Jain and Mr. Abhiroop Jayanthi as directors. Shareholders will also vote on a ₹4 crore performance incentive for Whole-time Director & CEO - Animal Health, Mr. Rajaram Narayanan. Remote e-voting is open from May 30 to June 28, 2026.
The appointment of new directors and the approval of performance incentives are significant for the company's governance and executive compensation structure. These decisions can influence future strategic direction and operational management, hence having a medium impact.
The announcement concerns routine corporate governance procedures like director appointments and performance incentives, which are standard business practices and do not inherently indicate a positive or negative outlook for the company.
Viyash Scientific Limited (formerly Sequent Scientific Limited) has issued a Postal Ballot Notice dated May 19, 2026, seeking shareholder approval for key corporate actions. The notice includes three agenda items: the appointment of Mr. Amit Jain and Mr. Abhiroop Jayanthi as Non-Executive, Non-Independent Directors, and the approval of a one-time performance incentive of ₹4 crore for Mr. Rajaram Narayanan, Whole-time Director & CEO - Animal Health.
The remote e-voting process for these resolutions will commence on Saturday, May 30, 2026, at 9:00 AM IST and conclude on Sunday, June 28, 2026, at 5:00 PM IST. The company has engaged National Securities Depository Limited (NSDL) to facilitate the e-voting. The results of the postal ballot are expected to be announced on or before Tuesday, June 30, 2026.
Mr. Amit Jain (DIN: 06917608) and Mr. Abhiroop Jayanthi (DIN: 10354445) were initially appointed as Additional Directors by the Board on April 22, 2026, and their appointments are now subject to shareholder approval. The one-time performance incentive of ₹4 crore for Mr. Rajaram Narayanan is to be paid during the financial year ending March 31, 2027. The company has provided detailed instructions for members to participate in the remote e-voting process.
What to do with a filing like this
Viyash Scientific Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Viyash Scientific Limited. Read the original for the full detail.